Challenges in Clinical Trial Implementation: Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC)

Anna Weiss, Nicole E. Lopez, Erin P. Ward, Katherine C. Lee, Abigail S. Caudle, Diana Dickson-Witmer, Cecilia Chang, Kaitlyn Kelly, Linda Williams Martin, Lisa Kay Jacobs, Kelly K. Hunt, Katherine Yao, Sarah L. Blair

Research output: Contribution to journalArticle

Abstract

Background: Although the results of clinical trials often guide best practices, changing clinical practice based on clinical trial results can be challenging. The objective of this study was to examine provider-reported barriers to adopting best clinical practices according to clinical trial data. Methods: A cross-sectional survey was conducted of providers from the National Accreditation Program for Breast Centers about barriers that prevent the incorporation of trial findings. Descriptive analyses and multivariable analyses were performed to determine provider characteristics that were significantly associated with reported barriers. Results: Overall, 383 institutions participated (63.5% response rate), with a total of 1226 physicians responding to the survey (80% response rate). Providers identified national guidelines and meetings as the most compelling way to receive practice-changing information. They reported the following internal barriers to trial implementation: patient preference (45%), strongly held beliefs by partners/colleagues (37%), and insufficient time to discuss new practices (30%). External barriers preventing trial implementation included a lack of agreement from multidisciplinary tumor boards (32%), fear of reimbursement loss (23%), and resistance from clinical staff (20%). Reported barriers differed by provider specialty, with plastic surgeons and radiation oncologists reporting that strongly held beliefs by partners/colleagues and disagreement from multidisciplinary tumor boards were the most significant factors preventing clinical trial implementation. Conclusions: Physician beliefs and patient preferences are the most frequently reported barriers to clinical trial implementation. Tactics to better educate providers about how to explain new clinical trial data to their patients and colleagues are needed.

Original languageEnglish (US)
Pages (from-to)4364-4371
Number of pages8
JournalAnnals of Surgical Oncology
Volume26
Issue number13
DOIs
StatePublished - Dec 1 2019

Fingerprint

Accreditation
Breast
Clinical Trials
Patient Preference
Practice Guidelines
Physicians
Fear
Surveys and Questionnaires
Neoplasms
Cross-Sectional Studies
Guidelines

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Weiss, A., Lopez, N. E., Ward, E. P., Lee, K. C., Caudle, A. S., Dickson-Witmer, D., ... Blair, S. L. (2019). Challenges in Clinical Trial Implementation: Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC). Annals of Surgical Oncology, 26(13), 4364-4371. https://doi.org/10.1245/s10434-019-07807-9

Challenges in Clinical Trial Implementation : Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC). / Weiss, Anna; Lopez, Nicole E.; Ward, Erin P.; Lee, Katherine C.; Caudle, Abigail S.; Dickson-Witmer, Diana; Chang, Cecilia; Kelly, Kaitlyn; Martin, Linda Williams; Jacobs, Lisa Kay; Hunt, Kelly K.; Yao, Katherine; Blair, Sarah L.

In: Annals of Surgical Oncology, Vol. 26, No. 13, 01.12.2019, p. 4364-4371.

Research output: Contribution to journalArticle

Weiss, A, Lopez, NE, Ward, EP, Lee, KC, Caudle, AS, Dickson-Witmer, D, Chang, C, Kelly, K, Martin, LW, Jacobs, LK, Hunt, KK, Yao, K & Blair, SL 2019, 'Challenges in Clinical Trial Implementation: Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC)', Annals of Surgical Oncology, vol. 26, no. 13, pp. 4364-4371. https://doi.org/10.1245/s10434-019-07807-9
Weiss, Anna ; Lopez, Nicole E. ; Ward, Erin P. ; Lee, Katherine C. ; Caudle, Abigail S. ; Dickson-Witmer, Diana ; Chang, Cecilia ; Kelly, Kaitlyn ; Martin, Linda Williams ; Jacobs, Lisa Kay ; Hunt, Kelly K. ; Yao, Katherine ; Blair, Sarah L. / Challenges in Clinical Trial Implementation : Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC). In: Annals of Surgical Oncology. 2019 ; Vol. 26, No. 13. pp. 4364-4371.
@article{f8016fc96dc744759e6adaf3442d727f,
title = "Challenges in Clinical Trial Implementation: Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC)",
abstract = "Background: Although the results of clinical trials often guide best practices, changing clinical practice based on clinical trial results can be challenging. The objective of this study was to examine provider-reported barriers to adopting best clinical practices according to clinical trial data. Methods: A cross-sectional survey was conducted of providers from the National Accreditation Program for Breast Centers about barriers that prevent the incorporation of trial findings. Descriptive analyses and multivariable analyses were performed to determine provider characteristics that were significantly associated with reported barriers. Results: Overall, 383 institutions participated (63.5{\%} response rate), with a total of 1226 physicians responding to the survey (80{\%} response rate). Providers identified national guidelines and meetings as the most compelling way to receive practice-changing information. They reported the following internal barriers to trial implementation: patient preference (45{\%}), strongly held beliefs by partners/colleagues (37{\%}), and insufficient time to discuss new practices (30{\%}). External barriers preventing trial implementation included a lack of agreement from multidisciplinary tumor boards (32{\%}), fear of reimbursement loss (23{\%}), and resistance from clinical staff (20{\%}). Reported barriers differed by provider specialty, with plastic surgeons and radiation oncologists reporting that strongly held beliefs by partners/colleagues and disagreement from multidisciplinary tumor boards were the most significant factors preventing clinical trial implementation. Conclusions: Physician beliefs and patient preferences are the most frequently reported barriers to clinical trial implementation. Tactics to better educate providers about how to explain new clinical trial data to their patients and colleagues are needed.",
author = "Anna Weiss and Lopez, {Nicole E.} and Ward, {Erin P.} and Lee, {Katherine C.} and Caudle, {Abigail S.} and Diana Dickson-Witmer and Cecilia Chang and Kaitlyn Kelly and Martin, {Linda Williams} and Jacobs, {Lisa Kay} and Hunt, {Kelly K.} and Katherine Yao and Blair, {Sarah L.}",
year = "2019",
month = "12",
day = "1",
doi = "10.1245/s10434-019-07807-9",
language = "English (US)",
volume = "26",
pages = "4364--4371",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "13",

}

TY - JOUR

T1 - Challenges in Clinical Trial Implementation

T2 - Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC)

AU - Weiss, Anna

AU - Lopez, Nicole E.

AU - Ward, Erin P.

AU - Lee, Katherine C.

AU - Caudle, Abigail S.

AU - Dickson-Witmer, Diana

AU - Chang, Cecilia

AU - Kelly, Kaitlyn

AU - Martin, Linda Williams

AU - Jacobs, Lisa Kay

AU - Hunt, Kelly K.

AU - Yao, Katherine

AU - Blair, Sarah L.

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Background: Although the results of clinical trials often guide best practices, changing clinical practice based on clinical trial results can be challenging. The objective of this study was to examine provider-reported barriers to adopting best clinical practices according to clinical trial data. Methods: A cross-sectional survey was conducted of providers from the National Accreditation Program for Breast Centers about barriers that prevent the incorporation of trial findings. Descriptive analyses and multivariable analyses were performed to determine provider characteristics that were significantly associated with reported barriers. Results: Overall, 383 institutions participated (63.5% response rate), with a total of 1226 physicians responding to the survey (80% response rate). Providers identified national guidelines and meetings as the most compelling way to receive practice-changing information. They reported the following internal barriers to trial implementation: patient preference (45%), strongly held beliefs by partners/colleagues (37%), and insufficient time to discuss new practices (30%). External barriers preventing trial implementation included a lack of agreement from multidisciplinary tumor boards (32%), fear of reimbursement loss (23%), and resistance from clinical staff (20%). Reported barriers differed by provider specialty, with plastic surgeons and radiation oncologists reporting that strongly held beliefs by partners/colleagues and disagreement from multidisciplinary tumor boards were the most significant factors preventing clinical trial implementation. Conclusions: Physician beliefs and patient preferences are the most frequently reported barriers to clinical trial implementation. Tactics to better educate providers about how to explain new clinical trial data to their patients and colleagues are needed.

AB - Background: Although the results of clinical trials often guide best practices, changing clinical practice based on clinical trial results can be challenging. The objective of this study was to examine provider-reported barriers to adopting best clinical practices according to clinical trial data. Methods: A cross-sectional survey was conducted of providers from the National Accreditation Program for Breast Centers about barriers that prevent the incorporation of trial findings. Descriptive analyses and multivariable analyses were performed to determine provider characteristics that were significantly associated with reported barriers. Results: Overall, 383 institutions participated (63.5% response rate), with a total of 1226 physicians responding to the survey (80% response rate). Providers identified national guidelines and meetings as the most compelling way to receive practice-changing information. They reported the following internal barriers to trial implementation: patient preference (45%), strongly held beliefs by partners/colleagues (37%), and insufficient time to discuss new practices (30%). External barriers preventing trial implementation included a lack of agreement from multidisciplinary tumor boards (32%), fear of reimbursement loss (23%), and resistance from clinical staff (20%). Reported barriers differed by provider specialty, with plastic surgeons and radiation oncologists reporting that strongly held beliefs by partners/colleagues and disagreement from multidisciplinary tumor boards were the most significant factors preventing clinical trial implementation. Conclusions: Physician beliefs and patient preferences are the most frequently reported barriers to clinical trial implementation. Tactics to better educate providers about how to explain new clinical trial data to their patients and colleagues are needed.

UR - http://www.scopus.com/inward/record.url?scp=85074593479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074593479&partnerID=8YFLogxK

U2 - 10.1245/s10434-019-07807-9

DO - 10.1245/s10434-019-07807-9

M3 - Article

C2 - 31625045

AN - SCOPUS:85074593479

VL - 26

SP - 4364

EP - 4371

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 13

ER -